Clinical Trials Browser

Has results × Melanoma × GSK2141795 × Clear all

NCT01902173 2025-01-14

Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer

Phase 1/2 Completed

27 enrolled 16 charts

DermatologicOther hematologic neoplasm

Melanoma, Neoplasm Metastasis, Hematologic Neoplasms

NCT01941927 2020-02-12

Trametinib With GSK2141795 in BRAF Wild-type Melanoma

Phase 2 Completed

20 enrolled 16 charts

Melanoma